Search Results - "Burland, L"

Refine Results
  1. 1

    Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival by Cummings, M, Merone, L, Keeble, C, Burland, L, Grzelinski, M, Sutton, K, Begum, N, Thacoor, A, Green, B, Sarveswaran, J, Hutson, R, Orsi, N M

    Published in British journal of cancer (14-07-2015)
    “…Background: Variations in systemic inflammatory response biomarker levels have been associated with adverse clinical outcome in various malignancies. This…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Large single daily dose of histamine H2 receptor antagonist for duodenal ulcer. How much and when? A clinical pharmacological study by Deakin, M, Glenny, H P, Ramage, J K, Mills, J G, Burland, W L, Williams, J G

    Published in Gut (01-05-1987)
    “…The effects of single doses of cimetidine 800, 1200, and 1600 mg, given at 2300 h or 800, and 1600 mg at 1800 h, have been studied in patients with duodenal…”
    Get full text
    Journal Article
  8. 8

    Cimetidine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative study by Burland, W. L., Hawkins, B. W., Beresford, J.

    Published in Postgraduate medical journal (01-03-1980)
    “…Comparison of cimetidine and placebo in the prevention of recurrence of ulceration was carried out in the study of 696 patients with recently healed duodenal…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Oxmetidine: clinical pharmacological studies with a new H2-receptor antagonist by Mills, J G, Brunet, P L, Griffiths, R, Hunt, R H, Vincent, D, Milton-Thompson, G J, Burland, W L

    Published in Gut (01-02-1982)
    “…The gastric antisecretory effects of oxmetidine, a new H2-receptor antagonist, have been studied in 33 healthy subjects. The relative potency of oxmetidine…”
    Get full text
    Journal Article
  11. 11

    Prolactin responses to histamine H2 receptor antagonists by Sharpe, P C, Melvin, M A, Mills, J G, Burland, W L, Groom, G V

    Published in Acta endocrinologica (Copenhagen) (01-11-1980)
    “…We have compared the effects of cimetidine and SK&F 92994, a new more potent histamine H2 receptor antagonist, on serum prolactin, and also assessed the effect…”
    Get more information
    Journal Article
  12. 12

    Cardiovascular effects in man of intravenous prizidilol hydrochloride (SK&F 92657); a new antihypertensive agent by Edmonstone, WM, Manghani, KK, Bell, AJ, McLeod, M, Milton‐Thompson, GJ, Burland, WL

    Published in British journal of clinical pharmacology (01-10-1981)
    “…1 Cardiovascular responses to intravenous prizidilol hydrochloride (SK&F 92657) 0.86 mg/kg were studied in eight supine resting healthy volunteers. Five…”
    Get full text
    Journal Article
  13. 13

    The pharmacokinetics in man of SK&F 93319--a new antagonist of histamine H1 and H2 receptors by Johnson, P, Griffiths, R, Lee, R M, McDowall, R D, Doyle, E, Taylor, D C, Burland, W L

    Published in Xenobiotica (01-07-1984)
    “…SK&F 93319, a potent histamine H1- and H2-receptor antagonist, is rapidly absorbed with a low rate of plasma clearance primarily by metabolism. Excretion is…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Measles vaccination by the intradermal route by Burland, W. L.

    Published in Postgraduate medical journal (01-05-1969)
    “…Live further-attenuated measles vaccines have been given to two groups of children in the United Kingdom by either the intradermal or subcutaneous routes. The…”
    Get full text
    Journal Article
  16. 16

    Cardiovascular responses in healthy subjects to a novel oral dopamine agonist, fenoldopam by Cregeen, R J, Rudge, P J, Mills, J G, Vincent, S H, Burland, W L

    Published in Journal of hypertension. Supplement (01-12-1985)
    “…Two double-blind randomized crossover studies were carried out in healthy male subjects to determine the cardiovascular effects of fenoldopam and to assess…”
    Get more information
    Journal Article
  17. 17

    Response of Low Birthweight Infants to Treatment with Folic Acid by Burland, W. L., Simpson, K., Lord, Juliet

    Published in Archives of disease in childhood (01-04-1971)
    “…Folate deficiency, detected by measuring serum and red cell levels, was seen within a group of low birthweight infants who had been followed for a period of 9…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Advantages of Aluminium Hydroxide Adsorbed Combined Diphtheria, Tetanus, and Pertussis Vaccines for the Immunization of Infants by Butler, N. R., Voyce, M. A., Burland, W. L., Hilton, Marjorie L.

    Published in British Medical Journal (15-03-1969)
    “…Three combined triple antigen vaccines were used to inoculate infants receiving primary immunization at 3 to 6 months of age. Laboratory potency and toxicity…”
    Get full text
    Journal Article
  20. 20

    Response to oral administration of pteroylmonoglutamic acid or pteroylpolyglutamate in newborn infants of low birth weight by Samuel, Pamela D., Burland, W. L., Simpson, K.

    Published in British journal of nutrition (01-09-1973)
    “…1. Newborn infants of low birth weight absorb both pteroylmonoglutamic acid and pteroylpolyglutamate. 2. There was a significant fall in serum folate…”
    Get full text
    Journal Article